Surgical and pharmacological treatment of childhood obesity
Authors:
Jan Boženský 1; Bohuslav Procházka 2
Authors‘ workplace:
Dětská obezitologická ambulance, Dětské oddělení, Nemocnice AGEL Ostrava-Vítkovice, a. s.
1; Ordinace praktického lékaře pro děti a dorost, Kutná Hora
2
Published in:
Čas. Lék. čes. 2023; 162: 357-359
Category:
Review Article
Overview
The increase in obesity prevalence has been slowing down in numerous countries recently. WHO Europe has organized surveillance of childhood obesity (Childhood Obesity Surveillance Initiative, COSI) since 2008, which observed the prevalence of overweight and obesity of 6–9-year-old children is followed during this study and proved this result.
The study Children’s Health 2016 showed that after a period of the global increase of obesity until 2011, there was in the Czech Republic a period of certain stabilization, in which there weren´t major changes in weight. Unfortunately, the covid pandemic changed this trend and the current data from 2021 showed in the Czech Republic a serious increase in childhood obesity. For these children will be necessary to use a new type of treatment of obesity as a surgical and pharmacological specific treatment.
Keywords:
childhood obesity, Childhood Obesity Surveillance Initiative (COSI), surgical and pharmacological therapy of childhood obesity
Sources
- Vážná A, Vignerová J, Brabec M et al. Influence of pandemic COVID-19 in prevalence of over-weight and obesity in Czech children. Int J Environ Res Public Health 2022; 19: 11902.
- Hodnocení růstu a vývoje dětí a mládeže. Růstové grafy. Dostupné na: www.szu.cz/publikace/data/rustove-grafy
- Hodnocení růstu a vývoje dětí a mládeže. Dětská obezita. Dostupné na: www.szu.cz/publikace/data/detska-obezita
- Bláha P, Vignerová J, Riedlová J et al. 6. Celostátní antropologický výzkum dětí a mládeže 2001. Česká republika. SZÚ, Praha, 2005.
- Vignerová J, Riedlová J, Bláha P a kol. 6. celostátní antropologický výzkum dětí a mládeže 2001. Česká republika. Souhrnné výsledky. PřF UK, SZÚ, Praha, 2006.
- Boženský J, Procházka B. Obezita dětí a dospívajících aneb co dělat s obézním dítětem v ambulanci dětského lékaře. Časopis lékařů českých 2020; 159: 111–117.
- Clarson CL, Mahmud FH, Baker JE et al. Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents but did not improve insulin resistance. Endocrine 2009; 36: 141–146.
- Kelly AS, Auerbach P, Barrientos-Perez M et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N Engl J Med 2020; 382 (22): 2117–2128.
- Danne T, Biester T, Kapitzke K et al. Liraglutide in an adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12–17 years. J Pediatr 2017; 181: 146–153.
- Fried M, Yumuk V, Oppert JM et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Surg 2014; 24 (1): 42–55.
- Bolling CF, Armstrong SC, Reichard KW et al. Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics 2019; 144 (6): e20193224.
- Sljivic S, Gusenoff JA. The obesity epidemic and bariatric trends. Clin Plast Surg 2019; 46 (1): 1–7.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain managementArticle was published in
Journal of Czech Physicians
Most read in this issue
- Artificial intelligence in medicine and healthcare: Opportunity and/or threat
- Trends in fertility and abortion in Czechia
- Questions and questionnaires about acute climacteric syndrome
- Zogala D. Artificial intelligence in medical imaging